Clinical Trial Update: Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) [Phase 3]

View source ↗

Summary

Phase 3 trial (ARIEL3) evaluating rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cancer has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-08-03